// App-Quantinova.ai

: Effect of controller prescribing according to rs1042713 genotype on asthma related quality of life in young people (PACT: a randomized controlled trial

Researchers

Presenter

  • Thomas Ruffles

Principal Investigators

  • Christina Jones

  • Colin Palmer

  • Steve Turner

  • Jonathan Grigg

  • Roger Tavendale

  • Fiona Hogarth

  • Petra Rauchhaus

  • Kristina Pilvinyte

  • Helen Smith

  • Roberta Littleford

  • Brian Lipworth

  • Somnath Mukhopadhyay

Medical Centers

  • Academic department of paediatrics, Royal Alexandra Children’s Hospital, Brighton & Sussex Medical School, Brighton, United Kingdom

  • Faculty of Health & Medical Sciences, University of Surrey, Guilford, United Kingdom

  • Division of Population and Health Genomics, University of Dundee, Ninewells Hospital & Medical School University of Dundee, Dundee, United Kingdom

  • Child Health, University of Aberdeen,, Aberdeen, United Kingdom

  • Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Tayside Clinical Trials Unit, University of Dundee, Dundee, United Kingdom

  • Tayside Medical Science Centre TASC, University of Dundee, Dundee, United Kingdom

  • Division of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, United Kingdom

  • Center for Clinical Research, University of Queensland, Brisbane, Australia

  • Scottish Centre for Respiratory Research, Ninewells Hospital, University of Dundee, Dundee, United Kingdom,

Locations

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved